Zhou, W., Li, Y., Gou, S., Xiong, J., Wu, H., Wang, C., . . . Liu, T. (2015). MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Oncotarget.
Chicago Style aipamenaZhou, Wei, Yongfeng Li, Shanmiao Gou, Jiongxin Xiong, Heshui Wu, Chunyou Wang, Haijiao Yan, and Tao Liu. "MiR-744 Increases Tumorigenicity of Pancreatic Cancer By Activating Wnt/β-catenin Pathway." Oncotarget 2015.
MLA aipamenaZhou, Wei, et al. "MiR-744 Increases Tumorigenicity of Pancreatic Cancer By Activating Wnt/β-catenin Pathway." Oncotarget 2015.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.